Change in use of specific NSCLC treatments?
改变特定的NSCLC治疗方法？
What proportion of your NSCLC patients would you conduct this test?
您的NSCLC患者中大概有多少比例的患者会去接受检测？
Conclusion Both ITP and NP regimens are effective for the advanced NSCLC.
结论ITP和NP方案是治疗晚期NSCLC较有效的方案。
How does this information impact on your management of your NSCLC patients?
这些信息是否会影响您对于NSCLC患者的诊治？
Detection of their expression might be helpful to predict prognosis of NSCLC.
检测它们的表达对预测患者预后有重要意义。
Conclusion 3dcrt can improve local control rate and survival quality for NSCLC.
结论3dcrt可有效提高NSCLC患者肿瘤局部控制率和生存质量。
What proportion of your NSCLC patients are on each of the specific tests mentioned?
对于你所治疗的NSCLC患者来说，使用上述每种检测的患者比例大致是多少？
We developed a five-gene signature that is closely associated with survival of patients with NSCLC.
我们发现了一个五基因标记与非小细胞肺癌的生存率有密切的关系。
Objective To investigate the expression of osteopontin (OPN) in non-small cell lung cancer (NSCLC).
目的研究骨桥蛋白(OPN)在非小细胞肺癌(NSCLC)中的表达。
Objective: To study the effect of Shenyi capsule on patients with non-small cell lung cancer (NSCLC).
目的观察参一胶囊对非小细胞肺癌的辅助治疗作用。
Several aspects need to be considered for the successful clinical development of PKC inhibitors in NSCLC.
PK C抑制剂在NSCLC中成功的临床应用还需要考虑到几个方面。
The results were confirmed using two additional adenocarcinoma NSCLC and two nonadenocarcinoma NSCLC cell lines.
用另外两种NSCLC的腺癌细胞株和两种NSCLC的非腺癌细胞株也证实了这种结果。
Objective: to study the immunohistochemical diagnosis of neuroendocrine differentiation in surgically resected NSCLC.
目的：探讨非小细胞肺癌神经内分泌分化的免疫组化诊断。
Many studies showed that DNA methylation is specific marker of NSCLC in its diagnosis, staging, treatment and prognosis.
研究显示，DNA甲基化是非小细胞肺癌（NSCLC）诊断、分期及治疗预后特异性较强的标识物。
Objective: To study the nursing methods in the treatment of NSCLC by cryosurgery(Ar-He knife) combined with chemotherapy.
前言： 目的：探讨氩氦刀联合化疗治疗非小细胞肺癌患者的护理方法。
Objective: To study the nursing methods in the treatment of NSCLC by cryosurgery (Ar-He knife) combined with chemotherapy.
目的：探讨氩氦刀联合化疗治疗非小细胞肺癌患者的护理方法。
A total of 2281 patients with NSCLC were screened for EGFR mutations in their tumors and, of this group, 327 had mutations.
对总共2281名NSCLC患者肿瘤组织进行EGFR变异筛查。在这些患者中，327例患者检测到变异。
Objective:To compare the clinical activity, survival and toxicity of IVP and CAP for advanced non small cell cancer(NSCLC)in aged.
目的对比IVP方案与CAP方案治疗老年晚期非小细胞肺癌的临床疗效、生存期及毒副反应。
Objective To investigate the economic effects of three chemotherapy schemes in the treatment of non- small cell lung cancer (NSCLC).
目的探讨晚期非小细胞肺癌（NSCLC）不同化疗方案的临床疗效和经济学效果。
Conclusion "Qiyelin Granule" can improve the clinical symptoms and signs of NSCLC patients without causing evident harmful reactions.
结论“七叶灵”颗粒配合化疗可以有效改善患者的临床症状和体征，无明显不良反应。
Objective To discuss the diagnostic value of detecting sulfate glycosaminoglycan fragments (SGF) in non-small cell lung cancer (NSCLC).
目的探讨血清硫酸粘多糖片段（SGF）检测在非小细胞肺癌（NSCLC）的诊断价值。
Conclusion a certain part of NSCLC have NE differentiation, which has different biological features from NSCLC without NE differentiation.
结论NSCLC中有相当一部分伴有ne分化，NSCLC NE具有与其它NSCLC不同的生物学特性。
Conclusion NSE should be used in adjuvant diagnosing, preoperative histological typing and therapy monitoring for SCLC, and gastrin for NSCLC.
结论NSE主要用于SCLC的辅助诊断、术前组织学分型及疗效监测，而胃泌素用于NSCLC。
PURPOSE: To determine the epidemiology, pathology and patterns of care for patients with non-small cell lung cancer (NSCLC) in the United States.
目的：为了测定美国非小细胞肺癌患者的流行病学、病理学和治疗模式。
Methods With flow cytometry, expression of CD44 and apoptosis cell peak were detected in 28 fresh specimens of NSCLC and normal pulmonary specimens.
方法取新鲜NSCLC标本28例，应用流式细胞术测定CD44，同时测定凋亡细胞峰，并与癌旁肺组织进行比较。
Objective: To compare the clinic effect and the adverse effect of Delisheng injection with NP regimen in advanced non-small cell lung cancer (NSCLC).
目的：对比观察得力生注射液与NP方案治疗晚期非小细胞肺癌的临床疗效和毒副反应。
Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC).
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。
Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).
目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。
The TNM lung cancer staging system is primarily utilized for non-small-cell lung cancer (NSCLC), which accounts for approximately 75% of lung cancer diagnoses.
肺癌的TNM系统最初用于非小细胞癌(NSCLC)，这种癌大约占所有肺癌的75%。
The TNM lung cancer staging system is primarily utilized for non-small-cell lung cancer (NSCLC), which accounts for approximately 75% of lung cancer diagnoses.
肺癌的TNM系统最初用于非小细胞癌(NSCLC)，这种癌大约占所有肺癌的75%。
应用推荐